The Latest in Breast Cancer

Oncology Practice

Eribulin fails to best capecitabine in advanced breast cancer

December 12, 2012

Breast Cancer

Oncology Practice

ONC-CHAT: Dr. Martine Piccart, 'Absolutely No Advantage' to 2 Years of Trastuzumab

December 11, 2012

Breast Cancer

Oncology Practice

Studies put kibosh on statins for breast cancer prevention

December 10, 2012

Oncology Practice

Adjuvant Chemotherapy Boosts Survival in Locoregional Recurrent Breast Cancer

December 10, 2012

Breast Cancer

Oncology Practice

ONC-CHAT: What Did You Learn this Week that Will Change the Way You Work?

December 8, 2012

Breast Cancer

Oncology Practice

San Antonio Roundtable, Part 4: Everolimus in Clinical Practice, a New CDK Inhibitor

December 7, 2012

Breast Cancer

Oncology Practice

Late Leukemia Risk Rises after Breast Cancer Therapy

December 7, 2012

Oncology Practice

Genetic Vulnerabilities Identified in Residual TNBC After Neoadjuvant Chemo

December 7, 2012

Breast Cancer

Oncology Practice

ONC-CHAT: What Captured Your Imagination?

December 7, 2012

Breast Cancer

Oncology Practice

San Antonio Roundtable, Part 3: Trastuzumab, Bevacizumab, and Angiogenesis Inhibitors

December 7, 2012

Breast Cancer

Oncology Practice

ONC-CHAT: 'VOGL, NEW YORK' on 10 Years of Tamoxifen

December 7, 2012

Breast Cancer

Oncology Practice

PET/CT Pinpoints Physiological Evidence of Chemo Brain

December 7, 2012

Oncology Practice

San Antonio Roundtable, Part 2: CALOR Trial, Triple-Negative Breast Cancer

December 6, 2012

Breast Cancer

Oncology Practice

Mammograms Dip in Wake of USPSTF Recommendations

December 6, 2012

Breast Cancer

Oncology Practice

Bevacizumab Adds No Progression, Survival Benefits to Estrogen Therapy

December 6, 2012

Breast Cancer